非传统的T细胞影响异构血型细胞移植后临床结果

Lama Siblany1,2, Nicolas Stocker1,2, Laure Ricard1,2

  • 1INSERM, Centre de Recherche Saint-Antoine (CRSA), Sorbonne Université, F-75012, Paris, France.

概括

在全基造血细胞移植 (allo-HCT) 后,粘膜相关的不变T细胞 (MAIT) 和特定的玛-三角形 (γδ) T细胞子集的早期恢复显著改善了患者的生存率,并减少了GvHD. MAIT细胞频率和Vδ2+T细胞上的CD26表达是成功的alo-HCT结果的关键指标.

相关概念视频

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
68.1K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
706
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
324